ProCE Banner Activity

Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Clinical Evidence

Slideset

Download this slideset discussing the latest evidence and guideline recommendations for use of SGLT2 inhibitors, GLP-1 receptor agonists, and GIP/GLP-1 coagonists in patients with type 2 diabetes and obesity.

Released: December 05, 2023

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with Endocrine Society.

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

Endocrine Society

ProCE Banner